The risks and characteristics of the delayed bleeding after endoscopic submucosal dissection for early gastric carcinoma in cases with anticoagulants

References

• Park YM, Cho E, Kang HY, et al. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc. 2011;25(8):2666–2677.
   PubMed Web of Science ®Google Scholar
• Chung IK, Lee JH, Lee SH, et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc. 2009;69(7):1228–1235.
   PubMed Web of Science ®Google Scholar
• Isomoto H, Shikuwa S, Yamaguchi N, et al. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009;58(3):331–336.
   PubMed Web of Science ®Google Scholar
• Kataoka Y, Tsuji Y, Sakaguchi Y, et al. Bleeding after endoscopic submucosal dissection: risk factors and preventive methods. World J Gastroenterol. 2016;22(26):5927–5935.
   PubMed Web of Science ®Google Scholar
• Sato C, Hirasawa K, Koh R, et al. Postoperative bleeding in patients on antithrombotic therapy after gastric endoscopic submucosal dissection. World J Gastroenterol. 2017;23(30):5557–5566.
   PubMed Web of Science ®Google Scholar
• Okada K, Yamamoto Y, Kasuga A, et al. Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm. Surg Endosc. 2011;25(1):98–107.
   PubMed Web of Science ®Google Scholar
• Vinogradova Y, Coupland C, Hill T, et al. Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care. BMJ. 2018;4:k2505.
   Web of Science ®Google Scholar
• Barnes GD, Lucas E, Alexander GC, et al. National trends in ambulatory oral anticoagulant use. Am J Med. 2015;128(12):1300–1305. e2.
   PubMed Web of Science ®Google Scholar
• Brodie MM, Newman JC, Smith T, et al. Severity of gastrointestinal bleeding in patients treated with direct-acting oral anticoagulants. Am J Med. 2018;131(5):573.e9–e15.
   PubMed Web of Science ®Google Scholar
• Deutsch D, Romegoux P, Boustiere C, et al. Clinical and endoscopic features of severe acute gastrointestinal bleeding in elderly patients treated with direct oral anticoagulants: a multicentre study. Therap Adv Gastroenterol. 2019;12:1756284819851677.
   Web of Science ®Google Scholar
• Marco Garbayo JL, Koninckx Canada M, Perez Castello I, et al. Hospital admissions for bleeding events associated with treatment with apixaban, dabigatran and rivaroxaban. Eur J Hosp Pharm. 2019;26:106–112.
   PubMedGoogle Scholar
• Sanomura Y, Oka S, Tanaka S, et al. Taking warfarin with heparin replacement and direct oral anticoagulant is a risk factor for bleeding after endoscopic submucosal dissection for early gastric cancer. Digestion. 2018;97(3):240–249.
   PubMed Web of Science ®Google Scholar
• Yoshio T, Tomida H, Iwasaki R, et al. Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection. Dig Endosc. 2017;29(6):686–694.
   PubMed Web of Science ®Google Scholar
• Murasaki K. Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease (JCS 2009). Nihon Rinsho. 2011:69(Suppl 9):567–571.
   Google Scholar
• Izumikawa K, Iwamuro M, Inaba T, et al. Bleeding in patients who underwent scheduled second-look endoscopy 5 days after endoscopic submucosal dissection for gastric lesions. BMC Gastroenterol. 2018;18(1):46.
   PubMed Web of Science ®Google Scholar
• Koh R, Hirasawa K, Yahara S, et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc. 2013;78(3):476–483.
   PubMed Web of Science ®Google Scholar
• Mochizuki S, Uedo N, Oda I, et al. Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial): a multicentre prospective randomised controlled non-inferiority trial. Gut. 2015;64(3):397–405.
   PubMed Web of Science ®Google Scholar
• Association JGC. Japanese Gastric Cancer Treatment Guidelines 2014 (Ver. 4). Gastric Cancer. 2017;20:1–19.
   Web of Science ®Google Scholar
• Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014;26(1):1–14.
   PubMed Web of Science ®Google Scholar
• Goto O, Fujishiro M, Oda I, et al. A multicenter survey of the management after gastric endoscopic submucosal dissection related to postoperative bleeding. Dig Dis Sci. 2012;57(2):435–439.
   PubMed Web of Science ®Google Scholar
• Na S, Ahn JY, Choi KD, et al. Delayed bleeding rate according to the forrest classification in second-look endoscopy after endoscopic submucosal dissection. Dig Dis Sci. 2015;60(10):3108–3117.
   PubMed Web of Science ®Google Scholar
• Nam HS, Choi CW, Kim SJ, et al. Risk factors for delayed bleeding by onset time after endoscopic submucosal dissection for gastric neoplasm. Sci Rep. 2019;9(1):2674.
   PubMed Web of Science ®Google Scholar
• Yano T, Tanabe S, Ishido K, et al. Different clinical characteristics associated with acute bleeding and delayed bleeding after endoscopic submucosal dissection in patients with early gastric cancer. Surg Endosc. 2017;31(11):4542–4550.
   PubMed Web of Science ®Google Scholar
• Blech S, Ebner T, Ludwig-Schwellinger E, et al. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans. Drug Metab Dispos. 2008;36(2):386–399.
   PubMed Web of Science ®Google Scholar
• Okumura K, Inoue H, Atarashi H, et al. Validation of CHA2DS2-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry. Circ J. 2014;78(7):1593–1599.
   PubMed Web of Science ®Google Scholar
• Kagawa T, Iwamuro M, Ishikawa S, et al. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers. Aliment Pharmacol Ther. 2016;44(6):583–591.
   PubMed Web of Science ®Google Scholar
• Yoon JY, Shim CN, Chung SH, et al. Impact of tumor location on clinical outcomes of gastric endoscopic submucosal dissection. World J Gastroenterol. 2014;20(26):8631–8637.
   PubMed Web of Science ®Google Scholar
• Acosta RD, Abraham NS, Chandrasekhara V, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016;83(1):3–16.
   PubMed Web of Science ®Google Scholar
• Veitch AM, Vanbiervliet G, Gershlick AH, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Gut. 2016;65(3):374–389.
   PubMed Web of Science ®Google Scholar